More experimental Ebola drugs arrive

As part of ongoing efforts to contain the deadly Ebola Virus, the Government of Liberia has announced the arrival of an additional dosage of the experimental homeopathic drug in the country.

A Foreign Ministry release says a 3 kg package of experimental remedy containing sufficient doses for 30 infected persons in the treatment of Ebola arrived here from the International Emergency Management Organization (IEMO) in Italy.

The release says the arrival of the drug followed about two weeks of telephone conversational exchanges between Liberia’s Foreign Minister, Augustine Ngafuan and the Rome-based office of IEMO.

The IEMO says the consignment is an aqueous alternative medicine that promotes homeopathic cure with no side effect.

IEMO President, Dr. Alessandro Manini, in a phone conversation last Friday with Foreign Minister Ngafuan intimated that once the effectiveness of the remedy is confirmed by the Ministry of Health, his organization is ready to supply more at no cost to Liberia.

Meanwhile, Dr. Manini has lauded President Ellen Johnson Sirleaf and her Government for the efforts thus far to curb the Ebola virus, and pledged the full support of the IEMO and his personal commitment to the people of Liberia during this difficult period in arresting the spread of the virus.

He then expressed sympathy to families affected by the virus and promised his organization’s unflinching support to containing the outbreak. In furtherance of IEMO’s support to Liberia, Dr. Manini said he is planning a solidarity and assessment mission here in October.

In response, Foreign Minister Ngafuan, on behalf of President Sirleaf, the Government and People of Liberia, thanked Dr. Manini and the International Emergency Management Organization, for the timely intervention.

He affirmed Liberia’s support to the work of the IEMO and welcomed the decision of Dr. Manini to visit Liberia in October, intimating that the people of Liberia will be very happy to receive him, considering the assistance of his organization at this critical time.

Already, the Center for Disease Control of the United States has brought into the country the experimental Zmapp drug, which has been used on two doctors, but reportedly they did not survive.